Controlled Human Infection of Healthy Adults With Lyophilized Neisseria lactamica Induces Asymptomatic, Immunogenic Nasopharyngeal Carriage in the United Kingdom and Mali - Takeaways - MDSpire

Controlled Human Infection of Healthy Adults With Lyophilized Neisseria lactamica Induces Asymptomatic, Immunogenic Nasopharyngeal Carriage in the United Kingdom and Mali

  • By

  • D F Gbesemete

  • F Haidara

  • J R Laver

  • M Ibrahim

  • J MacLennan

  • A P Dale

  • A R Gorringe

  • Y Traore

  • F Diallo

  • H Badji

  • A Traore

  • U Onwuchekwa

  • E Jones

  • C Webb

  • J Guy

  • A A Theodosiou

  • S N Faust

  • S O Sow

  • R S Heyderman

  • M D Tapia

  • R C Read

  • January 7, 2026

  • 0 min

Share

  • 1

    Lyophilized Neisseria lactamica (LyoNlac) was safely administered intranasally to healthy adults in the UK and Mali, showing no significant safety concerns.

  • 2

    In the UK, a dose of 105 CFU of LyoNlac achieved 100% colonization, while in Mali, 107 CFU resulted in a 65% colonization rate.

  • 3

    Colonized participants exhibited significant increases in Nlac- and Nmen-specific IgG levels, indicating an immune response post-inoculation.

  • 4

    The study suggests that LyoNlac could potentially reduce Neisseria meningitidis carriage and transmission in sub-Saharan Africa.

  • 5

    Future clinical trials are warranted to evaluate the effectiveness of LyoNlac in preventing meningococcal outbreaks in the meningitis belt.

Original Source(s)

Related Content